{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:29:05Z","timestamp":1790796545007,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,3,4]],"date-time":"2010-03-04T00:00:00Z","timestamp":1267660800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s00280-010-1266-4","type":"journal-article","created":{"date-parts":[[2010,3,3]],"date-time":"2010-03-03T14:11:03Z","timestamp":1267625463000},"page":"1087-1093","source":"Crossref","is-referenced-by-count":19,"title":["Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvement"],"prefix":"10.1007","volume":"66","author":[{"given":"Apostolia M.","family":"Tsimberidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Moulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aung","family":"Naing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agop Y.","family":"Bedikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Daring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaan","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razelle","family":"Kurzrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,4]]},"reference":[{"key":"1266_CR1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3816\/CCC.2008.n.032","volume":"7","author":"DG Power","year":"2008","unstructured":"Power DG, Healey-Bird BR, Kemeny NE (2008) Regional chemotherapy for liver-limited metastatic colorectal cancer. Clin Colorectal Cancer 7:247\u2013259","journal-title":"Clin Colorectal Cancer"},{"key":"1266_CR2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.suronc.2007.05.001","volume":"16","author":"VP Khatri","year":"2007","unstructured":"Khatri VP, Chee KG, Petrelli NJ (2007) Modern multimodality approach to hepatic colorectal metastases: solutions and controversies. Surg Oncol 16:71\u201383","journal-title":"Surg Oncol"},{"key":"1266_CR3","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s11605-006-0061-3","volume":"11","author":"TM Pawlik","year":"2007","unstructured":"Pawlik TM, Choti MA (2007) Surgical therapy for colorectal metastases to the liver. J Gastrointest Surg 11:1057\u20131077","journal-title":"J Gastrointest Surg"},{"key":"1266_CR4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/00007611-198105000-00017","volume":"74","author":"AY Bedikian","year":"1981","unstructured":"Bedikian AY, Kantarjian H, Young SE et al (1981) Prognosis in metastatic choroidal melanoma. South Med J 74:574\u2013577","journal-title":"South Med J"},{"key":"1266_CR5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/01.iio.0000195852.08453.de","volume":"46","author":"AY Bedikian","year":"2006","unstructured":"Bedikian AY (2006) Metastatic uveal melanoma therapy: current options. Int Ophthalmol Clin 46:151\u2013166","journal-title":"Int Ophthalmol Clin"},{"key":"1266_CR6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/A:1025875332255","volume":"23","author":"SA Curley","year":"2004","unstructured":"Curley SA, Izzo F, Abdalla E et al (2004) Surgical treatment of colorectal cancer metastasis. Cancer Metastasis Rev 23:165\u2013182","journal-title":"Cancer Metastasis Rev"},{"key":"1266_CR7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/02841860151116367","volume":"40","author":"P Ragnhammar","year":"2001","unstructured":"Ragnhammar P, Hafstrom L, Nygren P et al (2001) A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol 40:282\u2013308","journal-title":"Acta Oncol"},{"key":"1266_CR8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/1097-0142(19890715)64:2<379::AID-CNCR2820640207>3.0.CO;2-8","volume":"64","author":"F Safi","year":"1989","unstructured":"Safi F, Bittner R, Roscher R et al (1989) Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial\/intravenous therapy). Results of a controlled clinical trial. Cancer 64:379\u2013387","journal-title":"Cancer"},{"key":"1266_CR9","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1200\/JCO.2005.17.749","volume":"23","author":"H Kelly","year":"2005","unstructured":"Kelly H, Goldberg RM (2005) Systemic therapy for metastatic colorectal cancer: current options, current evidence. J Clin Oncol 23:4553\u20134560","journal-title":"J Clin Oncol"},{"key":"1266_CR10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ctrv.2004.04.002","volume":"30","author":"FD Barber","year":"2004","unstructured":"Barber FD, Mavligit G, Kurzrock R (2004) Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview. Cancer Treat Rev 30:425\u2013436","journal-title":"Cancer Treat Rev"},{"key":"1266_CR11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S1470-2045(00)00419-8","volume":"2","author":"N Kemeny","year":"2001","unstructured":"Kemeny N, Fata F (2001) Hepatic-arterial chemotherapy. Lancet Oncol 2:418\u2013428","journal-title":"Lancet Oncol"},{"key":"1266_CR12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00000421-199410000-00010","volume":"17","author":"LG Feun","year":"1994","unstructured":"Feun LG, Reddy KR, Yrizarry JM et al (1994) A phase I study of chemoembolization with cisplatin and lipiodol for primary and metastatic liver cancer. Am J Clin Oncol 17:405\u2013410","journal-title":"Am J Clin Oncol"},{"key":"1266_CR13","first-page":"3040","volume":"7","author":"O Lyass","year":"2001","unstructured":"Lyass O, Hubert A, Gabizon AA (2001) Phase I study of doxil-cisplatin combination chemotherapy in patients with advanced malignancies. Clin Cancer Res 7:3040\u20133046","journal-title":"Clin Cancer Res"},{"key":"1266_CR14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205\u2013216","journal-title":"J Natl Cancer Inst"},{"key":"1266_CR15","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1200\/JCO.2005.03.6723","volume":"24","author":"MJ Ratain","year":"2006","unstructured":"Ratain MJ, Eisen T, Stadler WM et al (2006) Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma. J Clin Oncol 24:2505\u20132512","journal-title":"J Clin Oncol"},{"key":"1266_CR16","unstructured":"http:\/\/ctep.cancer.gov\/"},{"key":"1266_CR17","first-page":"524","volume":"26","author":"NE Kemeny","year":"1999","unstructured":"Kemeny NE, Ron IG (1999) Hepatic arterial chemotherapy in metastatic colorectal patients. Semin Oncol 26:524\u2013535","journal-title":"Semin Oncol"},{"key":"1266_CR18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00280-006-0239-0","volume":"59","author":"JW Jang","year":"2007","unstructured":"Jang JW, Bae SH, Choi JY et al (2007) A combination therapy with transarterial chemo-lipiodolization and systemic chemo-infusion for large extensive hepatocellular carcinoma invading portal vein in comparison with conservative management. Cancer Chemother Pharmacol 59:9\u201315","journal-title":"Cancer Chemother Pharmacol"},{"key":"1266_CR19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00280-004-0829-7","volume":"54","author":"JW Jang","year":"2004","unstructured":"Jang JW, Park YM, Bae SH et al (2004) Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma. Cancer Chemother Pharmacol 54:415\u2013420","journal-title":"Cancer Chemother Pharmacol"},{"key":"1266_CR20","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2214\/ajr.181.5.1811327","volume":"181","author":"S Sumie","year":"2003","unstructured":"Sumie S, Yamashita F, Ando E et al (2003) Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization. AJR Am J Roentgenol 181:1327\u20131334","journal-title":"AJR Am J Roentgenol"},{"key":"1266_CR21","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1200\/JCO.1994.12.6.1204","volume":"12","author":"YZ Patt","year":"1994","unstructured":"Patt YZ, Charnsangavej C, Yoffe B et al (1994) Hepatic arterial infusion of floxuridine, leucovorin, doxorubicin, and cisplatin for hepatocellular carcinoma: effects of hepatitis B and C viral infection on drug toxicity and patient survival. J Clin Oncol 12:1204\u20131211","journal-title":"J Clin Oncol"},{"key":"1266_CR22","doi-asserted-by":"crossref","unstructured":"Yodono H, Takekawa SD, Tarusawa K et al (1994) Combination therapy consisting of arterial infusion chemotherapy (EPF, EAP) and transcatheter arterial embolization (TAE). Cancer Chemother Pharmacol 33 (Suppl) : S79\u2013S83","DOI":"10.1007\/BF00686673"},{"key":"1266_CR23","doi-asserted-by":"crossref","unstructured":"Yodono H, Sasaki T, Tarusawa K, et al. (1992) Arterial infusion chemotherapy for advanced hepatocellular carcinoma using EPF and EAP therapies. Cancer Chemother Pharmacol 31 (Suppl) : S89\u2013S92","DOI":"10.1007\/BF00687114"},{"key":"1266_CR24","first-page":"59","volume":"22","author":"M Cantore","year":"2003","unstructured":"Cantore M, Fiorentini G, Mambrini A et al (2003) Regional combined with systemic chemotherapy in unresectable biliary tract cancers: a phase II study. J Exp Clin Cancer Res 22:59\u201364","journal-title":"J Exp Clin Cancer Res"},{"key":"1266_CR25","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/cncr.20964","volume":"103","author":"M Cantore","year":"2005","unstructured":"Cantore M, Mambrini A, Fiorentini G et al (2005) Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors. Cancer 103:1402\u20131407","journal-title":"Cancer"},{"key":"1266_CR26","first-page":"3009","volume":"27","author":"A Mambrini","year":"2007","unstructured":"Mambrini A, Guglielmi A, Pacetti P et al (2007) Capecitabine plus hepatic intra-arterial epirubicin and cisplatin in unresectable biliary cancer: a phase II study. Anticancer Res 27:3009\u20133013","journal-title":"Anticancer Res"},{"key":"1266_CR27","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/annonc\/mdf262","volume":"13","author":"M Cantore","year":"2002","unstructured":"Cantore M, Rabbi C, Guadagni S et al (2002) Intra-arterial hepatic chemotherapy combined with continuous infusion of 5-fluorouracil in patients with metastatic cholangiocarcinoma. Ann Oncol 13:1687\u20131688","journal-title":"Ann Oncol"},{"key":"1266_CR28","first-page":"172","volume":"21","author":"T Iida","year":"2003","unstructured":"Iida T, Hirata N, Hirakawa M et al (2003) Preoperative intraarterial infusion chemotherapy for advanced gastric cancer\u2014a retrospective review of four cases. Radiat Med 21:172\u2013177","journal-title":"Radiat Med"},{"key":"1266_CR29","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/(SICI)1097-0142(19990901)86:5<775::AID-CNCR12>3.0.CO;2-M","volume":"86","author":"CG Leichman","year":"1999","unstructured":"Leichman CG, Jacobson JR, Modiano M et al (1999) Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: a Southwest Oncology Group pilot trial. Cancer 86:775\u2013781","journal-title":"Cancer"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-010-1266-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-010-1266-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-010-1266-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T10:07:06Z","timestamp":1559038026000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-010-1266-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,4]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["1266"],"URL":"https:\/\/doi.org\/10.1007\/s00280-010-1266-4","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,4]]}}}